Rosacea Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Rosacea Market is segmented by Drug Class (Antibiotics, Alpha Agonists, Retinoid, Corticosteroids, Immunosuppressants, and Other Drug Classes), Mode of Administration, and Geography.

Market Snapshot

rosacea market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.21 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • Rosacea is a common skin disease, which causes redness and visible blood vessels on the face. It commonly affects middle-aged women who have fair skin. Although there is no cure for rosacea, treatments can control and reduce the signs and symptoms associated with the disease.
  • As per the National Rosacea Society, United States, the prevalence of rosacea during 2018 was highest when self-reported, with a rate of 9.71 %( 737,960,000), while the rate of dermatologist-diagnosed rosacea was 5.53 % (420,280,000). It has been observed in several studies that this is more common in fair-skinned individuals.
  • With rising prevalence, the awareness among the physicians and societies has also increased, which further drives the demand of this market. However, the presence of generic drugs to curb the related symptoms hinders the growth of the rosacea market.

Scope of the Report

Rosacea is a condition diagnosed by symptoms, such as facial flushing, coarseness of skin, and an inflammatory papulopustular eruption resembling acne.

By Drug Class
Antibiotics
Alpha Agonists
Retinoid
Corticosteroids
Immunosuppressants
Other Drug Classes
By Mode of Administration
Topical
Oral
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Antibiotics is Estimated to Witness Healthy Growth Over the Forecast Period

For over 60 years, antibiotics have been prescribed as a treatment for the symptoms of rosacea. It can reduce the number of acne pimples and bacterial inflammation or redness around the acne pimples. Antibiotics are available in two forms, including oral antibiotics and topical antibiotics. Oral antibiotics, such as tetracycline, doxycycline, and minocycline, have been proven to control rosacea's bacterial component and also has inflammatory benefits. It is most commonly preferred by physicians and doctors for early relief from the disease, but are usually for a long period, which drives the sales of this segment over other sub segments. So, the high usage of antibiotics for the treatment of rosacea is the main factor for the growth of the market. However, there are certain side effects associated with the usage of antibiotics, including bloating, loss of appetite, abdominal pain, and many others, which are restraining their adoption as a treatment.

Graph.png

To understand key trends, Download Sample Report

North America is Expected to Maintain the Largest Share in the Rosacea Market

North America has multiple factors, which support the growth of this market, better than other geographic regions. Some factors include high healthcare expenditure by the government each year on pharmaceuticals and medical devices and awareness in the society (several societies organizing campaigns across the US and Canada). As per the estimates of the National Rosacea Society (NRS), about 16 million Americans suffer from rosacea and maybe millions more in temporary remission. The companies also prefer to release their products first in the United States, due to favorable regulatory requirements, which drives the demand for this market

Geo.png

To understand geography trends, Download Sample Report

Competitive Landscape

The rosacea market has observed growing competition among leading players, majorly across the developed markets. Some of the major market players include Bausch Health Companies Inc., Nestlé (Galderma), Leo Pharma Inc., Hovione FarmaCiencia SA, and Aclaris Therapeutics, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence and Prevalence of Rosacea

      2. 4.2.2 Increasing Inclination toward Combination Products

    3. 4.3 Market Restraints

      1. 4.3.1 Increased Use of Generic Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Drug Class

      1. 5.1.1 Antibiotics

      2. 5.1.2 Alpha Agonists

      3. 5.1.3 Retinoid

      4. 5.1.4 Corticosteroids

      5. 5.1.5 Immunosuppressants

      6. 5.1.6 Other Drug Classes

    2. 5.2 By Mode of Administration

      1. 5.2.1 Topical

      2. 5.2.2 Oral

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Aclaris Therapeutics

      2. 6.1.2 Amorepacific Corporation

      3. 6.1.3 Bausch Health Companies Inc.

      4. 6.1.4 Foamix Pharmaceuticals

      5. 6.1.5 Hovione FarmaCiencia SA

      6. 6.1.6 Leo Pharma Inc.

      7. 6.1.7 Nestlé

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Rosacea Market market is studied from 2018 - 2026.

The Rosacea Market is growing at a CAGR of 6.21% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Aclaris Therapeutics, Leo Pharma Inc., Hovione FarmaCiencia SA, Bausch Health Companies, Nestlé (Galderma) are the major companies operating in Rosacea Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!